Begin typing your search above and press return to search.
K Radhakrishnan
access_time 21 Sep 2023 4:00 AM GMT
Womens quota in legislatures
access_time 20 Sep 2023 5:24 AM GMT
Extended Congress CWC meet raises hopes
access_time 19 Sep 2023 5:11 AM GMT
The saboteurs in the market of hate
access_time 18 Sep 2023 9:47 AM GMT
CAG report amidst Keralas financial crisis
access_time 16 Sep 2023 4:28 AM GMT
Vigilance needed, even for prevention
access_time 15 Sep 2023 5:17 AM GMT
Schools breeding hatred
access_time 14 Sep 2023 10:37 AM GMT
access_time 16 Aug 2023 5:46 AM GMT
Remembering the Teachers
access_time 5 Sep 2023 6:24 AM GMT
Homechevron_rightWorldchevron_rightChina's two vaccines...

China's two vaccines found to be safe, effective against COVID

Chinas two vaccines found to be safe, effective against COVID

Two vaccines made by China's Sinopharm have appeared to be safe and effective against COVID-19, according to a study published in a prestigious U.S. medical journal.

The first time detailed findings from a late-stage trial of a Chinese shot have appeared in the scientific literature.

The report, published online in the Journal of the American Medical Association on May 26 concluded the two vaccines are about 73 per cent and 78 per cent effective, as Sinopharm has previously claimed.

The readings were based on calculations over 142 symptomatic cases in a trial involving more than 40,000 participants, with 26 injected with the Wuhan unit's vaccine and 21 with the Beijing unit's shot, the report said.

Even though the vaccine is already being used in many countries, scientists had been waiting for more details about the two vaccines for a while.

One vaccine has recently won the backing of the World Health Organisation for emergency use.

The two inactivated vaccines developed by Sinopharm's vaccine-making unit China National Biotec Group Co. prevented symptomatic infections largely in line with what the state-owned drugmaker previously announced.

There's nothing very surprising. It's consistent with what they have claimed previously, but it does not completely eliminate the doubts about Sinopharm, said Jin Dong-yan, a medical professor at the University of Hong Kong who was not involved with the study.

The published study revealed some limitations in the vaccine trial. The testing was heavily skewed toward men, who accounted for nearly 85% of the participants. Less than 2% were aged 60 or older, and most were healthy. As a result, there is little evidence about the efficacy and safety among women, the elderly and those with underlying diseases.

The World Health Organization cleared one of Sinopharm's Covid shots earlier this month, paving the way for it to be more widely distributed around the world through the Covax facility that provides access to safe and effective vaccines.

Show Full Article
TAGS:SinopharmCovid19 updates
Next Story